Andrei Metelitsa, MD, FRCPC, FAAD

Institute for Skin Advancement
Market Mall Professional Building

4935 40th Avenue NW, Suite 206
Calgary, Alberta, Canada
T3A 2N1
403-284-4222


Specialty: Dermatology

Dr. Andrei Metelitsa, Dermatologist 

Research Interests: Acne, Actinic Keratosis, Atopic Dermatitis, Melasma, Psoriasis, Rosacea, Skin Cancer

 

 

Dr. Andrei Metelitsa, FRCPC, FAAD is a board-certified dermatologist in both Canada and United States and is currently Clinical Associate Professor at the University of Calgary. He graduated from medical school at the University of Alberta, Canada at the age of 23. He further received a 5-year dermatology training at the University of Alberta. After completing his residency, Dr. Metelitsa pursued an additional 1-year fellowship training in Lasers and Cosmetic Surgery in Boston, Massachusetts at SkinCare Physicians under the direction of world-renowned faculty from Harvard and Yale.

 

His main cosmetic interests include use of non-invasive techniques including fillers and neuromodulators (Botox and Dysport), as well as non-invasive body contouring, tattoo removal, and fractional resurfacing. In fact, he was the first physician in Canada to launch Dysport to cosmetic physicians across the country and is a frequent invited speaker at numerous cosmetic meetings.

 

His medical interests include skin cancer, acne and psoriasis. Dr. Metelitsa is currently involved in a number of clinical trials investigating new treatments for these conditions.

 

Dr. Metelitsa is an author of a dermatology book (Stedman’s Illustrated Dictionary of Dermatology Eponyms), as well as more than 40 book chapters and articles. He has presented at numerous national and international conferences and events and has been interviewed by multiple newspapers, radio channels, as well as television networks, including CBC, Global and CTV. He also acts as a reviewer for major dermatology journals, including Journal of the American Academy of Dermatology and Dermatologic Surgery, among others.

 

Dr. Metelitsa has received more than 35 academic, research, leadership and volunteer awards throughout his career. For his leadership, he has been honoured with the prestigious Royal College of Physicians and Surgeons Resident Leadership Award, University of Alberta Alumni Award of Excellence, and Canadian Dermatology Association Residents and Fellows Society Resident Teacher Award. He was also chosen to attend the American Academy of Dermatology Leadership Forum for future Leaders.

 

For his research, Dr. Metelitsa has been awarded the Pacific Dermatology Association Victor Newcomer Young Investigator Award, the North American Clinical Dermatologic Society Research Award, as well as multiple University of Alberta research awards. He continues to be heavily involved in numerous clinical trials investigating novel treatments and devices.

 

Dr. Metelitsa also volunteers on a number of boards and is a strong advocate for skin cancer prevention. For his efforts, he has been repeatedly inducted into the American Academy of Dermatology Leadership Circle of Volunteerism and has also received the President’s Volunteer Service Award.


Click to view Dr. Andrei Metelitsa's Publications

Carruthers J, Solish N, Humphrey S, Rosen N, Muhn C, Bertucci V, Swift A, Metelitsa A, Rubio RG, Waugh J, Quiring J, Shears G, Carruthers A. Injectable daxibotulinumtoxinA for the treatment of glabellar lines: a phase 2, randomized, dose-ranging, double-blind, multicenter comparison with onabotulinumtoxinA and placebo. Dermatol Surg 2017 Jun 12 [Epub ahead of print]. PMID: 28614091 / doi: 10.1097/DSS.0000000000001206

Gooderham M, Bourcier M, de Gannes G, Dhadwal G, Fahim S, Gulliver W, Landells I, Lynde C, Metelitsa A, Nigen S, Poulin Y, Pratt M, Shear NH, Siddha S, Taher Z, Vender R. Management of Chronic Hand Dermatitis: A Practical Guideline for the General Practitioner. Skin Therapy Letter - Family Practice Edition 2016; 11(1)

Canadian Psoriasis Guidelines Addendum Committee. 2016 Addendum to the Canadian Guidelines for the Management of Plaque Psoriasis 2008. J Cutan Med Surg 2016 Sep; 20(5): 375-431. Epub 2016 Jul 15. PMID: 27421294 / doi: 10.1177/1203475416655705

Saedi N, Metelitsa A. Commentary on q-switched 660-nm versus 532-nm Nd: YAG laser for the treatment for facial lentigines in Asian patients. Dermatol Surg 2015 Dec; 41(12):1396-7. PMID: 26551774 / doi: 10.1097/DSS.0000000000000543

Green JB, Cohen JL, Kaufman J, Metelitsa AI, Kaminer MS. Therapeutic approaches to cellulite. Semin Cutan Med Surg 2015 Sep; 34(3):140-3. PMID: 26566570 / doi: 10.12788/j.sder.2015.0169

Green JB, Metelitsa AI, Kaufman J, Keaney T. Laser and Light-Based Aesthetics in Men. J Drugs Dermatol 2015 Sep; 14(9):1061-4. PMID: 26355628

Bonazza S, Dalton B, Hardin J, Metelitsa A. Histiocytoid variant of Sweet Syndrome associated with azacitidine and recurrence upon rechallenge. Can J Hosp Pharm 2015 Jul-Aug; 68(4):339-41. PMID: 26327709

Kuzel P, Mahmood MN, Metelitsa AI, Salopek TG. A clinicopathologic review of a case series of dermatofibrosarcoma protuberans with fibrosarcomatous differentiation. J Cutan Med Surg 2015 Jan-Feb; 19(1):28-34. Epub 2015 Jan 1. PMID: 25775660 / doi: 10.2310/7750.2014.13192

Freedman JR, Kaufman J, Metelitsa AI, Green JB. Picosecond lasers: the next generation of short-pulsed lasers. Semin Cutan Med Surg 2014 Dec; 33(4):164-8. PMID: 25830248 / doi: 10.12788/j.sder.0117

Fabi SG, Metelitsa AI. Future directions in cutaneous laser surgery. Dermatol Clin 2014 Jan; 21(1): 61-9. PMID: 24267422 / doi: 10.1016/j.det.2013.09.004

Alam M, Dover JS; ASDS Dermatologic Surgery Lexicon Task Force. American Society for Dermatologic Surgery dermatologic surgery drug and device nomenclature recommendations. Dermatol Surg 2013 Aug; 39(8): 1158-66. Epub 2013 Jun 24. PMID: 23795987 / doi: 10.1111/dsu.12253

Alam M, Dover JS; American Society for Dermatologic Surgery Lexicon Task Force; Subsection chairs; Alam M, Goldman MP, Kaminer MS, Orringer J, Waldorf H, Alam M, Avram M, Cohen JL, Draelos ZD, Dover JS, Hruza G, Kilmer S, Lawrence N, Lupo M, Metelitsa A, Nestor M, Ross EV. Abbreviations for device names: a proposed methodology with specific examples. Dermatol Surg 2013 Apr; 39(4): 548-50. Epub 2013 Feb 22. PMID: 23433100 / doi: 10.1111/dsu.12156

Saedi N, Metelitsa A, Petrell K, Arndt KA, Dover JS.  Treatment of tattoos with a picosecond alexandrite laser: a prospective trial.  Arch Dermatol 2012 Dec; 148(12): 1360-3. Epub 2012 Sep 17:1-4.  PMID: 22986470 / doi: 10.1001/archdermatol.2012.2894

Kuzel P, Metelitsa AI, Dover DC, Salopek TG.  Epidemiology of sebaceous carcinoma in Alberta, Canada, from 1988-2007.  J Cutan Med Surg 2012 Nov-Dec, 16(6): 417-423.  PMID: 23149197

Kuzel P, Metelitsa AI, Dover DC, Salopek TG.  Epidemiology of dermatofibrosarcoma protuberans in Alberta, Canada, from 1988-2007.  Dermatol Surg 2012 Sep; 38(9):1461-1468.  Epub 2012 Jun 12.  PMID: 22691126 / doi: 10.1111/j.1524-4725.2012.02482.x

Metelitsa AI.  Commentary: Can 1927-nm thulium fractional laser treatment truly remove seborrheic keratoses?  Dermatol Surg 2012 Jul; 38(7 Pt 1):1032.  PMID: 22759223 / doi: 10.1111/j.1524-4725.2012.02387.x

Metelitsa AI, Green JB.  Commentary: are all fractional resurfacing devices equal with regard to induction of fibrosis?  Dermatol Surg 2012 Mar; 38(3):443-444.  PMID: 22385223 / doi: 10.1111/j.1524-4725.2011.02219.x

Gragasin FS, Metelitsa AI.  Unilateral laterothoracic exanthem.  CMAJ 2012 Feb 21; 184(3):322.  Epub 2011 Oct 17.  PMID: 21989468 / doi: 10.1503/cmaj.110315

Spock C, Metelitsa AI, Kaufman J, Green JB.  Lasers and light sources to activate fibroblasts. Cosmetic Dermatology 2012 Jan; 25(1):27-33.

Hoy N, Leung AKC, Metelitsa AI, Adams, S.  New concepts in median nail dystrophy, onychomycosis and hand, foot, and mouth disease nail pathology.  ISRN Dermatology, 2012, Article ID 680163, doi 10.5402/2012/680163

Kuzel P, Green JB, Metelitsa AI.  Emerging trends and treatment approaches in nonmelanoma skin cancer: a Canadian perspective.  Journal of Cutaneous Medicine and Surgery 2011 Nov-Dec; 15(Suppl1):365-370.  PMID: 22469202 / doi: 10.2310/7750.2011.00003

Metelitsa AI, Fiorillo L.  Recurrent Gianotti-Crosti syndrome.  J Am Acad Dermatol 2011 Oct; 65(4):876-877.  PMID: 21920247

Metelitsa AI, Green JB.  Home-use laser and light devices for the skin: an update.  Semin Cutan Med Surg 2011 Sep; 30(3):144-147.  PMID: 21925367 / doi: 10.1016/j.sder.2011.05.005

Green JB, Metelitsa AI.  Introduction for Cosmeceuticals.  Semin Cutan Med Surg 2011 Sep; 30(3):139-140.  PMID: 21925365 / doi: 10.1016/j.sder.2011.06.001

Metelitsa AI.  Commentary: autologous platelet-rich plasma with fractional laser resurfacing. Dermatol Surg 2011 Aug; 37(4):469.  PMID: 21481065 / doi: 10.1111/j.1524-4725.2011.01937.x

Wu DC, Chan WW, Metelitsa AI, Fiorillo L, Lin AN.  Pseudomonas skin infection: clinical features, epidemiology, and management.  Am J Clin Dermatol 2011 Jun; 12(3):159-169.  PMID: 21469761 / doi: 10.2165/11539770-000000000-00000

Metelitsa AI, Dover JS.  Should we use light-emitting diode photomodulation to minimize radiation-induced dermatitis?  Dermatol Surg 2010 Dec; 36(12):1928.  PMID: 21171220

Metelitsa AI.  Commentary: treatment of facial postinflammatory hyperpigmentation with facial acne in Asian patients using a novel Q-switched neodymium-doped yttrium aluminum garnet laser. Dermatol Surg 2010 Sep; 36(9):1374-1380.  Epub 2010 Jul 9.  PMID: 20629692 / doi: 10.1111/j.1524-4725.2010.01644.x

Metelitsa AI, Lauzon GJ.  Tobacco and the skin.  Clin Dermatol 2010 Jul-Aug; 28(4):384-390.  PMID: 20620754

Jung GW, Metelitsa AI, Dover DC, Salopek TG.  Trends in incidence of nonmelanoma skin cancers in Alberta, Canada, 1988-2007.  Br J Dermatol 2010 Jul; 163(1):146-154.  Epub 2010 Apr 15.  PMID: 20394628 / 20645981

Metelitsa AI, Alster TS.  Fractionated laser skin resurfacing treatment complications: a review.  Dermatol Surg 2010 Mar; 36(3): 299-306.  Epub 2010 Jan 19.  PMID: 20100273

Metelitsa AI, Dover DC, Smylie M, de Gara CJ, Lauzon GJ.  A population-based study of cutaneous melanoma in Alberta, Canada (1993-2002).  J Am Acad Dermatol 2010 Feb; 62(2): 227-232.  Epub 2009 Dec 16.  PMID: 20018405

Metelitsa AI, Nguyen GK, Lin AN.  Imipramine-induced facial pigmentation: case report and literature review.  J Cutan Med Surg 2005 Dec; 9(6):341-345.  PMID: 17016757

Barankin B, Metelitsa AI, Schloss EH, Wasel NR.  Skin disorders in Ashkenazi Jews: a review.  Int J Dermatol 2005 Aug; 44(8):630-635.  PMID: 16101861

Freiman A, Bird G, Metelitsa AI, Barankin B, Lauzon GJ.  Cutaneous effects of smoking.  J Cutan Med Surg 2004 Nov-Dec; 8(6):415-423.  PMID: 15988548

Taher M, Metelitsa A, Salopek TG.  Surgical pearl: earlobe repair assisted by guidewire punch technique: a useful method to remove unwanted epithelial tracts caused by body piercing.  J Am Acad Dermatol 2004 Jul; 51(1):93-94.  PMID: 15243531

Metelitsa A, Barankin B, Lin AN.  Diagnosis of sports-related dermatoses.  Int J Dermatol 2004 Feb; 43(2):113-119.  PMID: 15125501

Tibbo P, Joffe K, Chue P, Metelitsa A, Wright E.  Global assessment of functioning following assertive community treatment in Edmonton, Alberta: a longitudinal study.  Can J Psychiatry 2001 Mar; 46(2):144-148.  PMID: 11280083

 

Copyright 2014 Probity Medical Research Inc. All Rights Reserved.

Login